Table:
begin	end	state
1	55	non-cytoplasmic
56	77	transmembrane
78	88	cytoplasmic
89	107	transmembrane
108	112	non-cytoplasmic
113	133	transmembrane
134	153	cytoplasmic
154	177	transmembrane
178	188	non-cytoplasmic
189	208	transmembrane
209	244	cytoplasmic
245	264	transmembrane
265	281	non-cytoplasmic
282	302	transmembrane
303	311	cytoplasmic
312	330	transmembrane
331	335	non-cytoplasmic
336	358	transmembrane
359	369	cytoplasmic
370	391	transmembrane
392	402	non-cytoplasmic
403	422	transmembrane
423	449	cytoplasmic

Input:
>WP_058859649.1 NCBI__GCF_001482365.1:WP_058859649.1
MPRNPETGRLEPDARTVNRAVAASAIGNATEWFDYGVYAVSVVYITQNFFPGEYGTILAL
STFAFSFLVRPLGGLFWGPLGDRLGRKRILALTIILMAGATFCIGLLPTVETIGIAAPIL
LILLRAVQGFSTGGEYGGAATFMAEYAPDKRRGFLGSFLEFGTLAGFALGSLIVLLGEVV
LGNDAMSEWGWRIPFLLAGPMGLVGLYLRSRLADSPVFQELEESGHTESSAGMALKDLVT
RYWRPMLIMTGLVIALNVVNYTLLSYMPTYLEGQTGMANRTVLTIMFVAQFAMMLVIPFA
GALSDRVGRKPMWYTSLIGLFVLAIPMYMLMANGFWWALLGFAVLGLLYIPQLATISATF
PAMFPTQVRYAGFAITYNLATAVFGGTAPLANEALIGATGNPLVPAFYMMAACVVGLVAV
RAMKETVGASLRGTEIPETKPQDLVRARS

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server